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1 Flow chemistry and Microfluidic reactor technology 
For chemists working into a common synthetic laboratory most equipment 
would look very familiar: they all work with standardized glassware, use 
somewhat sophisticated ways of stirring and different ways to heat (such as 
the use of microwaves). Indeed chemists have mainly been focused on the 
chemistry occurring inside the flasks or reaction vessels, making it in a very 
elaborated and successful manner. Despite their many advantages 
continuous flow processes have commonly used only in the industrial 
environment of chemical and biotechnological production.1 With continuous 
flow processes constant parameters (temperature, time, amount of 
reagents and solvent, efficient mixing etc.) can easily be assured. Over the 
past 15 years, miniaturization has entered the field of flow chemistry and 
modern developments commonly deal with micro- and minifluidic flow 
devices.2 With respect to heat and mass transfer, efficient mixing as well as 
precise parameter control, miniaturized flow devices have proven very 
beneficial for performing chemistry that is difficult to conduct under batch 
conditions. 
Flow chemistry will not completely or generally change the way chemists 
are performing synthesis in the future, despite the fact that the field 
experiences a dramatic increase in interest both in academia and industry. 
Flow chemistry will become a common enabling technology to perform 
synthesis in the laboratory.3 
Micro reaction Technology is a term widely used to describe the 
performance of reactions in a continuous manner, within well-defined 
reaction channels, where typical dimension are of the order <1000m and 
volumes, at a research level, span the microliter to milliliter range. Often, 
microreactors are constructed as planar devices with ducts or channels 
machined into a planar surface. 
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1.1 Micro versus minifluididc reactors 
Common miniaturized flow devices rely on reactors that have channels or 
tubes sized between 10 m to a few mm in inner diameter. The differences, 
advantages and disadvantages between micro- and minifluidic reactors are 
reported in Table 1. 
 
Table 1. Micro- versus minifluidic reactors 
Reactor Advantages Disadvantages 
Microfluidic 
(10-500 m i.d.) 
 high heat transfer 
surface to 
product volume ratio 
 good heat transfer 
capabilities 
 ideally suited for 
optimizing 
reaction conditions 
 efficient mixing 
 micro channel suffer 
from 
restricted flow capacity 
 high pressure drop 
 tendency to block  
Minifluidic 
(500 m-several mm 
i.d.) 
 improved flow capacities 
 lower pressure drop 
 no blocking of channel 
 preparation of multigram 
to 
multikilogram quantities 
 possibility to work with 
packed bed reactors 
 lower heat transfer 
surface 
 poorer heat transfer 
capabilities 
 
The range of scale of these microreactors (micro- and mini-) is sufficiently 
broad to allow synthesis of approximately 10 mg to an annual production 
rate of a desired compound. 
Microfluidic devices are mainly found in academic laboratories and in 
analytical and diagnostic applications. Mesofluidic devices are also of 
academic interest, particularly when combined with functionalized fixed bed 
materials, but have also become popular in the industrial context. 
High heat transfer capacities are achieved with small diameter channels 
favouring micro over mini flow reactors. But high pressure drops, a limited 
flow capacity and a tendency to block, are common problems with micro 
reactors. Micro reactors also suffer from the fact that it is very difficult to 
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utilize them for the production of substantial amounts of material. 
Technically it is difficult to overcome this problem even when massive 
parallelization is achieved. 
However, the scale of micro flow reactors makes them ideal tools for 
process development experiments. 
 
1.2 Three key factors in flow chemistry: residence time, flow 
rate and reactor volume 
With respect to stoichiometry and reaction time there are fundamental 
differences between batch and flow systems. In batch processes 
stoichiometry is defined by the concentration of chemical reagents and their 
volumetric ratio while in flow processes this is defined by the concentration 
of reagents and the ratio of their flow rate. In batch production the reaction 
time is determined by how long a vessel is held at a given temperature to 
reach full conversion. When chemistry is operated under flow conditions the 
reaction time is determined by the volume of the reactor and the bulk flow 
rate. It is desirable to reach full conversion inside the reactor with the 
highest possible flow rate. 
As the flow rate correlates with the residence time these factors determine 
how much products is formed in a given time. Under optimized conditions a 
flow reactor can be operated continuously as long as starting material are 
available and are pumped through the reactor. 
 
1.3 The relationship between flow, heat and pressure 
Initially, miniaturized flow devices have been used to perform highly 
exothermic reactions that are carried out at ambient temperature. In that 
context safety issues are matched due to the excellent mixing and heat 
transfer properties of these type of reactors. 
Lately, developments in this field have focused on reactions that require 
more than 20 minutes reaction time under classical batch conditions and 
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thus need to be heated in order to be rapidly carried out under continuous 
flow conditions. As a cold stream of reactants enters the reactor and 
residence time in a flow protocol ideally need to be in the order of a few 
minutes to allow high flow rates heating through the walls of a preheated 
reactor has to be very rapid. If “flash” heating can be guaranteed and 
pressure resistant micro-structured flow reactors are chosen the reaction 
temperature can be set well above the boiling point of the solvent even up 
to supercritical conditions thus leading to very short reaction times. 
Several strategies have been pursued to achieve “flash” heating. Beside 
external ovens microwave irradiation (MW) has been combined with flow 
devices. This is a very practical approach because microwave chemistry is 
otherwise difficult to scale in a batch environment. Under flow conditions, 
however, only the reactor has to be heated and not the reservoirs 
containing the starting materials and the products. 
 
1.4 Flow chemistry and Multistep synthesis 
Synthesis under flow conditions is ideally suited to perform multistep 
process using linearly assembled flow devices. While synthesis under 
batch conditions means that each intermediate product of a multistep 
synthesis has to be isolated in bulk, the situation is totally different under 
flow conditions. 
A continuously operated multistep synthesis uses linearly linked flow 
reactors, thereby work-up and isolation protocols are minimized. In 
addition, it is possible to create flow setup in which two short linear 
synthetic flow sequences converge into one flow device which allow 
production of complex molecules from two fairly complex building blocks 
(Figure 1). 
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Figure 1. Linear and convergent multistep flow synthesis 
 
 
Multistep flow synthesis may also be very advantageous when highly 
unstable intermediates are formed during the synthetic process. 
 
1.5 Scale up and Industrial application 
For a long time the chemical industry has relied on the continuous 
production of chemicals, in general for commodities and less much so for 
fine chemicals and pharmaceuticals. As no flow equipment on the 
laboratory scale was available until recently, the chemistry developed in the 
laboratory was based on batch processes. This means that often research 
was disconnected from process chemistry which led to many problems and 
extra optimizations or even total redesign of the initial synthetic strategy. 
With bench top flow systems some of these frustrations between process 
and research chemists will be reduced because an established flow 
process is readily scalable. The volume of a flow reactor is very small 
compared to the scale of the whole process; however, reaction parameter 
like temperature, concentration, composition of reactants established for a 
small scale flow process can directly be transferred to larger flow reactors, 
without the need for substantial alteration of the conditions. 
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When mini (meso) flow equipment is utilized for scale-up concepts the 
extension of product collection time or increase of the length or size of the 
microchannels or tube are valid strategy (scale out). 
On the contrary, the parallel operation of many identical channels 
(numbering up principle) can be envisaged, but from a process engineering 
point of view this strategy is regarded to be far from ideal because the 
individual flow systems must show identical flow properties and the system 
requires highly complex online monitoring. 
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1 Carbohydrates and Glycosylation reaction 
Carbohydrates play a fundamental role in signal transduction and vital 
molecular recognition phenomena. They are primarly involved in 
inflammatory processes, bacterial and viral invasions, tumor growth and 
metastasis, and many other crucial biological events.1 The diversity of roles 
played by carbohydrates makes them attractive targets for the development 
of novel drugs to treat cancer, infectious diseases, inflammation and 
cardiovascular disorders.2 However, there are still severe limitations to the 
development of saccharide-based drugs using carbohydrates synthesis: 
during the past decades only two pharmaceutical compound based on 
synthetic oligosaccharides have been approved for the market, the 
anticoagulant fondaparinux (ArixtraTM) and the antiviral zanamivir 
(RelenzaTM). 
Classical carbohydrate synthesis is a multistep process tipically afflicted by 
laborious protecting groups manipulations, often requiring tedious work-up 
and time-consuming purification steps.3 The most important transformation 
in the chemical synthesis of carbohydrates is the glycosylation reaction, 
that remains a challenging task. 
 
2 Glycosylation reaction 
The glycosylation reaction is the transformation that connects two sugar 
residues. The glycosidic bond is formed by a nuclephilic displacement of a 
leaving group (X) attached to the anomeric bond of a sugar residue (called 
glycosyl donor) by an alcohol ROH, or by the OH group of a partially 
protected sugar moiety (called glycosyl acceptor). The reaction is generally 
performed in the presence of an acidic activator, called promoter. The role 
of the promoter, in general used in catalytic amount, is to assist the 
departure of the leaving group (Scheme 1). 
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Scheme 1. General scheme of glycosylation reaction 
 
 
In the literature are present a lot of methods for glycosidic bond formation. 
The synthesis of disaccharides and oligosaccharides in general involves 
the linking of two polyfunctional compound. This kind of synthesis is much 
more complicated than the synthesis of other biopolymers because of the 
greater number of possibilities for the combination of monomeric units and 
because the glycosidic bond have to be formed in a stereoselective way. 
In Scheme 2 are outlined the general pathways for glycosylation reaction: 
over 90% of all the glycosylation reported formally proceeds via this general 
mechanistic pathway. 
 
Scheme 2. General mechanistic pathway for glycodic bond formation 
 
 
The good results of the glycosylation reactions depends on different 
issues:1) the structures and reactivity of glycosyl donors and acceptors; 2) 
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the nature of the promoter; 3) kind of substituents on both the saccharide 
units; 4) the preferred selectivity of the reaction toward the - or the -
anomeric form. 
 
2.1 Structure and reactivity of glycosyl donors and of glycosyl 
acceptor 
There are numerous glycosylation methods involving different glycosyl 
donors: the name of glycosylation method generally reflects the 
functionality of the glycosyl donor. 
 
Figure 2. Some example of glycosyl donors used in oligosaccaride synthesis 
 
 
The reactivity at the anomeric center depends in a large extent on the 
choice of the protecting groups, especially those at C-2. Glycosyl donors 
are classified in two main groups: armed donors (with ether groups) and 
disarmed donors (with ester or amide groups). Ester groups exert an 
inductive electron-withdrawing effect at the anomeric carbon making the 
formation of the oxonium ion a slower process. 
The reactivity of glycosyl donors may be controlled by different leaving 
groups: both the nature of the heteroatom and the substituent of the leaving 
group will affect the reactivity. 
With regard to the reactivity of the glycosyl acceptor, this depends on the 
nucloephilicity of the hydroxyl groups in partially protected carbohydrates. 
In particular, it depends on their nature (primary more reactive than 
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secondary), their spatial orientation (equatorial more reactive than axial), 
the conformation of the sugar and the presence of other protecting groups 
in the molecule. In general, electron-withdrawing effect and the steric 
hindrance of the protecting groups decrease the reactivity of the acceptor. 
 
2.2 Promoters, Solvents and Experimental Conditions 
The nature of the promoter, generally a Lewis acid, has an influence on the 
departure of the leaving group in the glycosyl donor. The nature of the 
promoter classifies the reactions as homogenous and heterogenous, with 
an implication for the stereoselectivity. 
The solvent also has an influence on the overall rate of the process and in 
particular on the stereochemistry, especially in the case of non-participating 
groups in the glycosyl donor. Anhydrous solvents are required to avoid the 
competition from water. The most used solvents have low polarity, like 
dichloromethane or ether; sometimes polar aprotic solvents are used, such 
as acetonitrile or nitromethane. Some solvents may interacts with the 
oxonium ion forming an intermediate that drives the prevalent formation of 
a single anomer. In Scheme 3 is reported the formation of two different 
intermediates when acetonitrile or diethyl ether are used as solvents. 
 
Scheme 3. Influence of the solvent on the glycosylation stereochemistry  
 
 
The experimental conditions are very critical for the success of the 
glycosylation reaction. Generally, the use of extremely dry solvents, inert 
atmosphere and molecular sieves (that act as acid scavenger) are needed. 
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In some cases, the order in which the reagents are added is also important. 
In the normal procedure (appropriate for less reactive disarmed donors) the 
promoter is added over a mixture of acceptor and donor. In the inverse 
procedure (used for highly reactive armed donors) the donor is added to a 
mixture of acceptor and promoter. 
It’s important to notice that the stereoselective formation of a new glycosidic 
bond depends on different factors such as the type of the leaving group at 
the anomeric carbon, the protection and substitution on the rection 
partners, the promoter, the solvent and the temperature. So it should be 
realize that there are no general methods or strategies for oligosaccharide 
synthesis, which is one of its greatest difficulty. 
 
2.3 Different procedures of glycosylation reaction by different 
activation 
From a chemical point of view, the synthesis of oligosaccharides still 
remains a challenge to synthetic chemists. In literature are reported a 
number of methods for glycoside bond formation. Although some methods 
are more popular than others, there is no universal protocol that can be 
applied to any combination of donor and acceptor. The two most popular 
and widespread are the glycosylations that involve trichloroacetimidates 
and thioglycosides. 
 
2.3.1 The trichloroacetimidate method 
Electron deficient nitriles are known to undergo direct and reversible base-
catalysed addition of alcohols to the triple bond system, providing O-alkyl 
imidates (Scheme 4). The free imidates can be directly isolated as stable 
adduct. 
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Scheme 4. General synthesis of O-alkyl imidates 
 
 
The reaction of a sugar hemiacetal in the presence of a base with 
trichloroacetonitrile gives the anomeric trichloroacetimidates (Scheme 5). In 
this way, the anomeric oxygen atom has been transformed into a good 
leaving group.4 
 
Scheme 5. General glycosyl trichloroacetimidates synthesis 
 
 
Taking into account the equilibrium between both anomers and the 
enhanced nuclophilicity of equatorial oxygen atoms (kinetic anomeric effect, 
Scheme 6), the equatorial (β)-trichloroacetimidate is generated with 
preference in a very rapid and reversible reaction. However, this product 
anomerizes in a slow base-catalyzed reaction through retro-anomerization 
of the oxide anion. A new trichloroacetonitrile addition by the more 
thermodynamically stable axial oxide anion provides the (α)-
trichloroacetimidate (thermodynamic anomeric effect, Scheme 6). 
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Scheme 6. Thermodynamic and kinetic control in trichloroacetimidates synthesis 
 
 
The equilibrium between the two trichloroacetimidates can be speeded up 
by stronger base. Both O-activated anomers can be obtained in pure form 
and high yield using different bases. In particular, strong bases like NaH or 
DBU are appropriate for axial trichloroacetmidates while weaker bases 
such as K2CO3 are incapable of promoting the retro-anomerization 
mechanism. 
Concerning the glycosylation step, reaction of donor and acceptor under 
very mild acidic conditions leads to the corresponding glycoside in an 
irreversible manner. In general, the reaction is promoted by a catalytic 
amount of a Lewis acid such as BF3
.OEt2 or TMSOTf (the most used). The 
proton liberated on the glycoside bond formation reacts with the forming 
leaving group leading to a stable, non-basic trichloroacetamide that 
provides the driving force of the glycosylation (Scheme 7). 
 
Scheme 7. Glycosylation with trichloroacetimidates 
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2.3.2 The thioglycoside method 
There are several methods in which the anomeric carbon is activated by 
groups having sulphur in place of the exocyclic hemiacetal oxygen. The 
best known example of this type of protection/activation group is the 
alkyl(aryl)thio group (thioglycosides). 
The sulphur atom in a thioglycoside is a soft nucleophile and is able to 
react selectively with soft electrophiles such as heavy metal cations, 
halogens and alkylating or acylating agents, making this kind of donors very 
versatile in carbohydrate chemistry. In addition, the hydroxyl and ring 
oxygen atom of carbohydrates are hard nucleophiles, which can be 
functionalized with strong reagents, without affecting alkyl(aryl)thio function 
(Scheme 8). 
 
Scheme 8. General synthesis and glycosylation 
 
With regards to the synthesis of thioglycosides, they can be prepared by an 
acid-promoted displacement at the anomeric center. This implies the 
reaction between a peracetylated sugar and a thiol in the presence of a 
Lewis acid as promoter, in general BF3
.OEt2 (Scheme 9). 
 
Scheme 9. Thioglycosides preparation 
 
 
Concerning the glycosylation reaction, an electrophile activates the 
thioglycoside by producing intermediate sulfonium ion, which then gives 
rise to glycosylating carbocationic intermediates that can react with the 
alcohol or the glycosyl acceptor giving the glycoside (Scheme 10). 
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Scheme 10. Activation and glycosylation of thioglycosides 
 
 
The first promoter used in a direct glycosylation involving thioglycosides 
was MeOTf: this promoter has disadvantages because it is toxic and, in the 
presence of slow reacting glycosyl donors, it can give rise to methyl ethers 
in addition to glycosides. For this reason, other thiophilic promoters have 
been developed. One of the most efficient promoter that produce fast 
reaction is the combination of N-iodosuccinimide and TfOH or TMSOTf. 
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1 Flow Chemistry and Carbohydrates 
Because of many advantages mentioned in the previous chapter (efficient 
mixing, good heat transfer, good control of reaction conditions, rapid 
screening of multiple reactions using a little amount of precious 
intermediates and simple scale-up), microreactors lend themselves 
particularly well for the accomplishment of organic transformations in which 
multiple factors determine the outcome of the reaction. In principle, the use 
microfluidic devices could speed up the saccharide drug discovery and 
development process, in order to adequately exploit the broad potential 
envisioned for this class of molecules in pharmaceutical and medicinal field. 
Nonetheless, only few applications of this technique to oligosaccharide 
synthesis have been reported in the literature, regarding both 
monosaccharide manipulations and glycosylation reactions. 
 
1.1 Protecting group manipulation 
In 2009 Fukase and co-authors reported the use of a microfluidic device to 
perform the reductive opening of sugar 4,6-O-benzylidene acetals, a key 
functional group in carbohydrate chemistry.1 Reductive opening of 
benzylidene acetals by the combination of acid/hydride reagents is one of 
the most useful transformation,2 since the benzyl-protected derivatives at 
either the C4- or C6-hydroxyl can be selectively prepared by the choice of 
reagents and/or solvent systems.3 
The typical procedure of the reductive opening of the acetals involves the 
very slow addition of the acid to a mixture of the substrate and excess 
hydride reagent at 0°C, followed by continuous stirring at room temperature 
for another few hours to ensure the completion of the reaction. To prevent 
the concomitant acid-catalyzed hydrolysis of the benzylidene ring it is 
important to control the addition speed of the acid (exothermic reaction). 
The yields of this reaction are not always reproducible, especially when it is 
performed on a large scale. 
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The authors decided to use a continuous flow microreactor to control the 
temperature, the mixing and the amount of hydride and acid (Figure 3). 
 
Figure 3. Schematic representation of reductive opening of benzylidene acetals under 
flow conditions 
 
Optimal conditions for reductive opening were examined using the glucose 
4,6-O-benzylidene acetal (Table 2, Entry 1). Substrate (0.1 M) and hydride 
(1.0 M) dissolved in CH2Cl2 were mixed with BF3
.OEt2 in CH2Cl2 at 0°C at 
the flow rate of 0.5 mL/min, thereafter the reaction mixture was allowed to 
flow at room temperature for 90 seconds through a reactor tube and 
quenched by saturated NaHCO3 solution at 0°C. Best reaction conditions 
were found using a solution of BF3
.OEt2 1.0M, obtaining the desired product 
in almost quantitative yield. By applying these established conditions and 
using the appropriate hydride donor, glucose, glucosamine and galactose 
4,6-O-benzylidene acetals were selectively transformed into the 
corresponding 6-O- or 4-O-benzyl derivatives (Table 2). 
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Table 2. Results of reductive opening of benzylidene acetals under flow conditions 
Entry Substrate Hydride Solvent Product 
Yield (%, 
microfluidic) 
Yield 
(%, 
batch) 
1 
 
Et3SiH 
(1.0 M) 
CH2Cl2 
 
93 58 
2 
 
BH3
.
Et2NH 
(0.5 M) 
CH2Cl2 
 
100 90 
3 
 
Et3SiH 
(1.0 M) 
CH2Cl2 
 
91 83 
4 
 
BH3
.
Et2NH 
(0.5 M) 
CH2Cl2 
 
100 86 
5 
 
BH3
.
Et2NH 
(0.5 M) 
CH3CN 
 
100 NA 
6 
 
Et3SiH 
(1.0 M) 
CH2Cl2 
 
91 62 
 
Another application of flow chemistry to protecting group manipulation was 
explored by Leino group in 2011 in the deprotection of benzyl/benzylidene 
protected carbohydrates.4 Benzyl ethers and benzylidene acetals are some 
of the most used protective group in carbohydrate chemistry, the main 
reasons being their stability toward a wide range of conditions and selective 
and mild removal conditions (mainly featuring hydrogenolyses). The 
commonly employed procedures to remove them utilizing batch reactors 
require long reaction times. The authors describes a rapid and efficient 
method of deprotection of different carbohydrates using a continuous flow 
hydrogenation reactor. 
This consist of a H2O-reservoir from which hydrogen gas is produced by 
electrolytic cleavage of water (this is a superior option for laboratory safety 
in comparison with classical batch reactor, in which hydrogen gas is taken 
from a bottle). The reaction was performed pumping the solution of the 
sample and the hydrogen gas through the catalyst (Pd/C) cartridge (Figure 
4). 
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Figure 4. Schematic representation of the continuous flow reactor 
 
 
The authors tested the flow conditions to different derivatives containing 
acid- and base labile protecting groups in order to ensure that the 
conditions would not influence other functional groups. 
In all cases, they obtained the desired products in good yield (Table 3). 
 
Table 3. Results of the deprotection 
Entry Substrate Product Yield (%) 
1 
  
95 
2 
  
95 
3 
  
95 
4 
  
90 
 
This method tolerates both acid- and base-sensitive functional groups 
(acetyl and silyl protective groups). The high efficiency, simple work-up and 
short reaction time should make this method appealing to a researcher 
working with carbohydrates. 
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1.2 Glycosylation reactions 
The first example of glycosylation reaction performed in a microfluidic 
reactor was reported by Seeberger and co-authors in 2005.5 The aim of the 
study was to find the best conditions in terms of temperature and reaction 
time to optimize the chemical yield and reduce the formation of side 
products. To perform the study they used a silicon microfluidic microreactor 
with an internal volume of 78.3 μL. The yield of the products were 
determined by HPLC using a UV-active compound (methyl 2,3,4,6-tetra-O-
benzyl--D-mannopyranoside) as standard added at the end of the reaction 
in the quench solution. 
The reactions studied involves the mannosyl trichloroacetimidate and two 
different acceptors (diisopropilidene galactose and methyl 2,3,4-tri-O-
benzyl--D-mannopyranoside) shown in Scheme 11. 
 
Scheme 11. Glycosylation reactions studied by Seeberger 
 
 
The reaction temperature was varied from -78 to 20°C using flow rates of 
10, 20, 40 and 80 μL/min, that resulted in residence time of 26.7, 53.4, 
106.8 and 213.5 seconds. 
HPLC analysis of the crude samples showed a clear relationship between 
reaction temperature, reaction time and formation of products. The results 
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of the experiments are reported in Figure 5. In general, the yield of product 
increase with the temperature (for a given residence time) or with the 
residence time (at low temperature) 
 
Figure 5. Glycosylation results 
 
 
In this case the authors find that, unlike batch methods, the use of 
microreactor allow to obtain comprehensive information about a 
transformation (like the glycosylation reaction). They performed 44 
reactions at varying temperature and reaction time using just over 2 mg of 
glycosylating agent for each reaction. 
In 2007 the same group reported another study on glycosylation reactions 
performed in a microfluidic reactor.6 In this case the authors used three 
mannose building blocks, pentenyl 3,4,6-tri-O-benzyl--D-
mannopyranoside as acceptor and two different donors 
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(trichloroacetimidate and phosphate, used for the first time in a 
microreactor, Scheme 12). 
 
Scheme 12. Glycosylations with trichloroacetimidate and phosphate 
 
 
The authors explored different reaction conditions, changing the flow rate, 
the solvent, the reagent quantities and the temperature. The conversion 
was determined by LC/MS analysis of the crude samples. The desired -
disaccharide was always the major product, although its distribution was 
highly dependent on reaction temperature and residence time; the 
formation of the orthoester was the main side reaction. The optimized 
reaction conditions for each glycosylating agent and solvent were 
determined and are reported in Figure 6. 
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Figure 6. Distribution for the optimized reaction conditions (yellow: -disaccharide, red: 
-disacharide, blue: orthoester) 
 
Also in this case the authors took advantages of the microreactor to 
compare different glycosylation parameters under various conditions, using 
only a little amount of starting materials. 
The last example of the use of microfluidic reactors in oligosaccharide 
synthesis was reported in 2009 by Fukase group.1 In this work the authors 
tried to perform β-mannosylation using a N-phenyl trifluoroacetimidate 
mannosyl donor. On milligram scale (20 mg) the reaction was carried out 
with good results in terms both of yield and stereoselectivity (84%, βα 
93:7); however, when the reaction was performed on 900 mg the yield 
decreases to 61% and the anomeric ratio decreases to βα 4.9:1 (with an 
addition of TMSOTf in one portion). So the authors decided to examine the 
microfluidic conditions based on the observation that the success of the 
glycosylation depends on the fast addition and the efficient mixing with the 
Lewis acid to produce the active intermediate at low temperature. The 
experiment was performed with un apparatus composed by a micromixer 
and a second batch reactor (Figure 7). 
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Figure 7. Glycosylation performer in microfluidic/batch system 
 
 
The optimal conditions in the integrated microfluidic/batch system were a 
micromixing at -90°C and a batch reaction at -50°C for 3 h: in these 
conditions the disaccharide was isolated in 92% yield and with an βα ratio 
of 5:1. In addition, the authors performed a scale-up of the optimized 
conditions by simply preparing stock solutions of substrate and reagents, 
and then continuously pumping them into the integrated microfluidic/batch 
apparatus. 
All these examples show that the microfluidic reactor technology is a really 
suitable technique to explore in detail the numerous experimental 
parameters determining the fate of a complex transformation such as the 
glycosylation reaction. 
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Abstract. Although carbohydrates offer new therapeutic opportunities in 
biomedical field, the industrial implementation of carbohydrate-based drugs 
is yet greatly thwarted by the difficulties and challenges inherent in 
oligosaccharide synthesis, especially for large scale preparation. Any tool 
or new technology enabling a cost-effective improvement of the lead 
generation process is therefore highly desirable in order to reduce the 
manufacturing costs of carbohydrate drugs. During last years, continuous-
flow synthesis in microreactors has gained a great deal of attention 
featuring practical advantages such as high reproducibility, easy scalability 
and fast reaction optimization using small amounts of reagents or synthetic 
intermediates. This technique may therefore offer an effective support to 
make carbohydrates more attractive targets for drug discovery processes. 
In addition, also basic research in academia can benefit from microreactor 
technology as a tool to improve the organic synthesis of oligosaccharides. 
Here we report a systematic exploration of the glycosylation reaction, the 
most important and difficult transformation in oligosaccharide synthesis, 
carried out in microreactors under continuous-flow conditions. Various 
trichloroacetimidates and thioglycosides have been investigated as glycosyl 
donors in this study, using both primary and secondary glycosyl acceptors. 
 39 
 
Each microfluidic glycosylation has been compared with the same reaction 
performed under traditional conditions, in order to highlight advantages and 
drawbacks of microreactors technology. As a significant example of 
multistep continuous-flow synthesis, we also describe the preparation of a 
trisaccharide by means of two consecutive glycosylations performed in two 
interconnected microreactors. 
 
Introduction 
Carbohydrates play a fundamental role in signal transduction and vital 
molecular recognition phenomena. They are primarily involved in 
inflammatory processes, bacterial and viral invasions, tumour growth and 
metastasis, and many other crucial biological events.1 The diversity of roles 
played by carbohydrates makes them attractive targets for the development 
of novel drugs to treat cancer, infectious diseases, inflammation, and 
cardiovascular disorders.2 However, there are still severe limitations to the 
development of saccharide-based drugs using traditional carbohydrate 
synthesis, even though some enormously successful pharmaceutical 
compounds based on synthetic oligosaccharides have been approved for 
the market during the past decade, such as the anticoagulant fondaparinux 
(ArixtraTM) and the antiviral zanamivir (RelenzaTM). 
Classical carbohydrate synthesis is a multistep process typically afflicted by 
laborious protecting groups manipulations, often requiring tedious work-up 
and time-consuming purification steps.3 In addition the glycosylation, the 
most important transformation in the chemical synthesis of carbohydrates, 
is still a challenging task. Although multitudinous approaches for the 
stereoselective formation of glycosidic bonds have steadily emerged for the 
last two decades,4 an efficient and general method to confidently prepare 
various glycoconjugates has yet been established, especially one that is 
applicable for large scale. As a consequence, the ideal reaction conditions 
(in terms of the protecting groups pattern of the condensing partners, 
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reagents concentration, stoichiometry, temperature and nature of the acidic 
promoter) have to be found, in theory, for each couple of glycosylation 
partners, leading to waste of time and high consumption of precious 
building blocks, which are valuable synthetic intermediates and they 
themselves require multistep synthesis. All of these drawbacks are inherent 
in carbohydrate synthesis and translate in huge hurdles for the industrial 
development of carbohydrate-based pharmaceutical compounds.  
Continuous-flow organic synthesis performed in microreactors offers an 
attractive potential solution, as it should enable rapid early-stage reaction 
optimization and direct scale-up.5 Due to the small dimensions and the 
increased surface to volume ratio of microreactors, mass and heat 
transport are significantly more efficient than in the classic round-bottomed 
flask. As a result, the reaction conditions in a continuous-flow microsystem 
are very homogenous, and variables such as temperature, pressure, 
concentration, and residence time (to be compared with the reaction time in 
a batch reaction) can be easily and precisely controlled, improving yield, 
purity and selectivity. In addition, the amount of starting material required to 
streamline a transformation of interest is dramatically reduced, so that a 
rapid screening of multiple reaction conditions is possible with a limited 
waste of precious intermediates. On the other hand, the scale-up of an 
optimized process can be achieved by continuous operation of the 
microreactor or running multiple reactors in parallel.  
Because of many practical advantages mentioned above, the use of 
microfluidic reactors could speed up the saccharide drug discovery and 
development process, in order to adequately exploit the broad potential 
envisioned for this class of molecules in pharmaceutical and medicinal field. 
Nonetheless, only few applications of this technique to oligosaccharide 
synthesis have been reported in the literature.6,5g 
With the purpose to gain more insights on the potential of microreactors in 
oligosaccharide synthesis, here we report a systematic study on the 
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glycosylation reaction performed under continuous-flow conditions using 
different glycosyl donors and acceptors. In particular, both primary and 
secondary acceptors (monosaccharides 1-3, Figure 8) have been used in 
this study, while thioglycosides –employed for the first time in 
microreactors– and glycosyl trichloroacetimidates have been selected as 
glycosyl donors. Each glycosylation has been also carried out under 
traditional batch conditions, in order to compare the results both in terms of 
chemical yield and stereoselectivity. 
Finally, we describe the straightforward preparation of a trisaccharide by 
means of two sequential microfluidic glycosylations, as a significant 
example of multistep synthesis that makes use of interconnected 
microreactors. 
 
Results and Discussion 
First, one primary (glucoside 1, Figure 8) and two secondary acceptors 
(compound 2 and the more sterically hindered glucoside 3, Figure 1) were 
synthesized from methyl α-D-glucopyranoside following known procedures.7 
Then, a panel of glycosyl donors differing for conformational rigidity and 
activating group at the anomeric carbon was synthesized according to 
literature procedures. In particular, the most popular and widespread 
classes of glycosyl donors, trichloroacetimidates and thioglycosides, were 
selected and employed in this study. Moreover, all the glycosyl donors do 
not have participating groups at C-2, so that a possible influence of the 
microfluidic conditions on the glycosylation stereoselectivity could emerge.  
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Figure 8. Glucosyl acceptors employed in this study. 
 
Glucosyl trichloroacetimidates 4 and 5 (Figure 9) were prepared as 
previously described.8 Ethyl- and p-tolyl- thioglycosides 6 and 7, and their 
corresponding more conformationally rigid counterparts 8 and 9 (Figure 9) 
were synthesized from pentaacetylglucose.9 
 
 
Figure 9. Glucosyl donors employed in this study. 
 
All the batch glycosylations were carried out at room temperature in dry 
CH2Cl2 under inert atmosphere. Flow glycosylations were instead 
performed at room temperature pumping into a microreactor with an 
internal volume of 13 μl two distinct solutions in reagent grade CH2Cl2, 
containing the glycosyl donor and acceptor (1.2:1 ratio, Solution A) and the 
acidic promoter (0.01 M TMSOTf, Solution B). In the glycosylations 
performed with thioglycosyl donors, Solution A contained also the N-
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iodosuccinimide (NIS) required for anomeric activation. A fine tuning of the 
hydrodynamic pumping (using a conventional double syringe pump) 
allowed to fix the flow rate, i.e. the residence time in the microreactor, 
corresponding to the reaction time. The device is completed by a reservoir 
connected to the outlet of the microreactor and containing a solution of 
triethylamine in CH2Cl2 to neutralize the promoter and quench the reaction 
(Figure 10).  
 
 
Figure 10. Diagramatic representation of continous-flow glycosylations 
 
In the first set of experiments, the trichloroacetimidate donor 4 was reacted 
with acceptors 1-3 (Scheme 13). Initially, the reaction time of both batch 
and microfluidic reactions was set at 5 min.  
 
 
Scheme 13. Reagents and reaction conditions: (a) 0.01 M TMSOTf, CH2Cl2 
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Although the unusual reaction environment (use of reagent grade instead of 
dry solvent, room temperature) all the flow glycosylations afforded the 
corresponding disaccharides 10-12 in moderate to good yields, comparable 
or even higher than the batch reactions (Table 4, entries 1-2, 6-7, and 9-
10). Interestingly, when the reaction time was further reduced to 1 min, a 
significant increase of the chemical yields was observed (Table 4, entries 3, 
8, 11), while the stereoselectivity -in terms of α:β ratio- remained almost 
unchanged. The most sterically hindered acceptor 3 provided exclusively 
the α disaccharide 12 under all the conditions tested (Table 4, entries 9-11). 
In a separate experiment, we investigated the influence of the temperature 
on the course of the microfluidic glycosylation of acceptor 1 with donor 4 
(Table 4, entries 4 and 5). However, going from room temperature to 0°C 
we observed only a slight increase of the chemical yield (and a decrease of 
the stereoselectivity), while at -20°C the precipitation of the 
trichloroacetamide caused the microchannels occlusion. All the following 
glycosylations were therefore performed at room temperature. 
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Table 4. Glycosylations performed with trichloroacetimidate donors 4 and 5 
entry conditions donor acceptor product 
time 
(min) 
yield 
(%)
a
 
α:β
b
 
1 batch 4 1 10 5 66 2.4:1 
2 flow 4 1 10 5 81 1.8:1 
3 flow 4 1 10 1 95 1.6:1 
4 flow 4 1 10 1
c
 99 1:1 
5 flow 4 1 10 1
d
 26
e
 1:1.8 
6 batch 4 2 11 5 28 1:1.3 
7 flow 4 2 11 5 50 1.3:1 
8 flow 4 2 11 1 77 1.6:1 
9 batch 4 3 12 5 58 1:0 
10 flow 4 3 12 5 50 1:0 
11 flow 4 3 12 1 85 1:0 
12 batch 5 1 13 5 62 5:1 
13 flow 5 1 13 1 92 3:1 
14 flow 5 1 13 0.5 93 4:1 
15 batch 5 2 14 5 71 6:1 
16 flow 5 2 14 1 62 6.5:1 
17 flow 5 2 14 0.5 65 6.5:1 
18 batch 5 3 15 5 56 15:1 
19 flow 5 3 15 1 60 9:1 
20 flow 5 3 15 0.5 57 19:1 
a
Isolated yield; 
b
 Determined by 
1
H-NMR; 
c
reaction performed at 0°C; 
d
reaction performed at -20°C; 
e
microchannels occlusion 
 
Trichloroacetimidate 5 afforded very similar results to donor 4, in terms of 
chemical yields (Scheme 13 and Table 4) and stereoselectivity. The only 
exception was again the glycosylation of acceptor 3. This reaction showed 
high α stereoselectivity under batch conditions (15:1 α:β ratio), and reached 
an excellent 19:1 with 0.5 min reaction time in the microreactor (Table 4, 
entries 18 and 20, respectively). We deemed that the good α 
stereoselectivity achieved only with acceptor 3 should be ascribed to 
matching steric effects, rather than to a specific influence of the microfluidic 
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conditions. On the other hand, the reduction of the reaction time to 0.5 min 
did not bring any apparent advantage with acceptors 1 and 2 (Table 4, 
compare entries 13-14, and entries 16-17). We therefore considered 1 min 
as the optimal reaction time for our system, and this value was fixed in all 
the subsequent experiments. 
In the next stage of our investigation we explored the behavior of 
thioglycosyl donors in microreactor. It should be emphasized that, to the 
best of our knowledge, this is the first example of use of thioglycosyl donors 
in glycosylations under continuous-flow conditions. The flow reactions were 
carried out by pumping in the microreactor a solution containing the donor, 
the acceptor and NIS, while a 0.01 M solution of TMSOTf was injected in 
the second inlet with a flow rate corresponding to 1 min reaction time. In 
this way, the activation of the glycosyl donor by I+ takes place in the 
microreactor soon after mixing the two solutions.  
Gratifyingly, glycosylations with thioglycosides 6–9 occurred smoothly at 
room temperature under microfluidic conditions, furnishing chemical yields 
and stereoselectivities absolutely comparable to batch reactions even if 
performed using reagent grade CH2Cl2 (Scheme 14 and Table 5).  
 
 
Scheme 14. Reagents and reaction conditions: (a) NIS, 0.01 M TMSOTf, CH2Cl2. 
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In particular, while flow glycosylations of acceptors 1 and 2 provided very 
similar or even higher yields than corresponding batch reactions (Table 5, 
entries 1–2, 3–4, 7–8, 9–10, 13–14, and 17–18), acceptor 3 afforded 
significantly lower yields (10-15% less) of disaccharides 12 and 15 under 
flow conditions with all thioglycosyl donors (Table 5, entries 5–6, 11–12, 
15–16, and 19–20). 
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Table 5. Glycosylations performed with thioglycosyl donors 6-9 
entry conditions donor acceptor product 
time 
(min) 
yield 
(%)
a
 
α:β
b
 
1 batch 6 1 10 5 71 1:1 
2 flow 6 1 10 1 81 1.4:1 
3 batch 6 2 11 5 69 2:1 
4 flow 6 2 11 1 67 1.8:1 
5 batch 6 3 12 5 90 3.5:1 
6 flow 6 3 12 1 76 5:1 
7 batch 8 1 13 5 80 4.5:1 
8 flow 8 1 13 1 70 3.4:1 
9 batch 8 2 14 5 55 4.5:1 
10 flow 8 2 14 1 56 4.4:1 
11 batch 8 3 15 5 88 2.6:1 
12 flow 8 3 15 1 60 3:1 
13 batch 7 1 10 5 68 1.6:1 
14 flow 7 1 10 1 81 1.5:1 
15 batch 7 3 12 5 86 3.9:1 
16 flow 7 3 12 1 69 5:1 
17 batch 9 1 13 5 65 4:1 
18 flow 9 1 13 1 80 4:1 
19 batch 9 3 15 5 88 2.9:1 
20 flow 9 3 15 1 75 4.8:1 
a
Isolated yield; 
b
Determined by 
1
H-NMR 
 
Finally, we explored the possibility to accomplish two consecutive 
glycosylation reactions in two interconnected microreactors. This is a 
crucial issue to convincingly establish the microfluidic devices as valuable 
tools to speed up the synthesis of even complex oligosaccharides in order 
to expand the industrial development of saccharide-based drugs.10 
Taking advantage of the well distinct mode of activation of 
trichloroacetimidates and thioglycosides, the experiment was designed and 
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carried out as follows (Scheme 15). A CH2Cl2 solution of 2-O-acetyl-3,4,6-
tri-O-benzyl-α-D-glucopyranosyl trichloroacetimidate 1611 and acceptor 17 –
obtained from thioglycoside 9 by reductive opening of the benzylidene 
acetal– and a 0.02 M CH2Cl2 solution of TMSOTf were pumped in the first 
microreactor, setting the reaction time at 2 min. The glycosylation occurred, 
then the solution containing the disaccharide thioglycoside 18 and TMSOTf 
flowed from the outlet of the microreactor and was directly conveyed to the 
inlet of the second microreactor, together with a CH2Cl2 solution of acceptor 
1 and NIS. Eventually, the newly formed trisaccharide 19 was recovered at 
the outlet of the second microreactor after neutralization of TMSOTf with 
triethylamine. Chromatographic purification provided trisaccharide 19 in 
51% overall yield. NMR analysis showed the exclusive formation of a β 
glycosidic bond in the first glycosylation (disaccharide 18), demonstrating 
that anchimeric assistance of the neighboring acetyl ester in donor 16 is 
preserved under microfluidic conditions. On the other hand, disaccharide 
donor 18 afforded a mixture of anomers (estimated as 6.3:1 α:β ratio by 
NMR) at the second glycosidic linkage of trisaccharide 19. 
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Scheme 15. Reagents and Reaction Conditions: (a) 0.02 M TMSOTf, CH2Cl2; (b) 0.05 M 1, 
NIS, CH2Cl2 
 
Conclusions 
We performed a systematic study to explore the application of 
microreactors technology in oligosaccharide synthesis. Two of the most 
widespread glycosyl donors, trichloroacetimidates and thioglycosides, were 
coupled with different glycosyl acceptors under batch and microfluidic 
conditions. We found that, in comparison with traditional batch reactions, 
the glycosylations carried out under continuous-flow conditions occur with 
very similar stereoselectivity and comparable or even higher chemical yield. 
However, microfluidic glycosylations have some practical advantages, such 
as the possibility to be performed in standard grade solvent at room 
temperature. Also thioglycosides, used for the first time in microreactors 
and which are notoriously highly sensitive to traces of moisture in the 
reaction mixture, afforded the corresponding disaccharides with high 
efficiency. 
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Further benefits of microreactors derive from their use for the multistep 
synthesis. Multistep flow reactions can indeed accelerate the development 
of efficient chemical processes for the discovery and production of 
saccharide-based lead compounds, enabling a drastic reduction of 
manufacturing costs. As a proof of concept, we synthesized a trisaccharide 
performing two consecutive glycosylations into interconnected 
microreactors. The large variety of glycosyl donors that can be activated in 
highly specific manner enables to design the multistep synthesis of even 
complex oligosaccharides profiting by the technical ease and flexibility of 
microreactors. 
All these characteristics feature the microreactors as a promising 
technology for the industrial development of carbohydrate-based 
pharmaceutical compounds. 
With the intent to explore drawbacks and potential of microfluidic devices in 
oligosaccharide synthesis, further efforts in this direction are currently 
underway in our laboratory. 
 
Experimental 
 
General procedures. The reactions performed under microfluidic 
conditions were carried out in a glass microreactor with an internal volume 
of 13 μL purchased by Micronit Microfluidics®. All commercially available 
reagents including dry solvents were used as received. Nonvolatile 
materials were dried under high vacuum. Reactions were monitored by 
thin-layer chromatography on pre-coated Merck silica gel 60 F254 plates 
and visualized by staining with a solution of cerium sulfate (1g) and 
ammonium heptamolybdate tetrahydrate (27 g) in water (469 mL) and 
concentrated sulfuric acid (31 mL). Flash chromatography was performed 
on Fluka silica gel 60. NMR spectra were recorded at 300 K on 
spectrometer operating at 400 MHz. Proton chemical shifts are reported in 
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ppm (δ) with the solvent reference relative to tetramethylsilane (TMS) 
employed as the internal standard (CDCl3 δ = 7.26 ppm). J values are 
given in Hz. Carbon chemical shifts are reported in ppm (δ) relative to TMS 
with the respective solvent resonance as the internal standard (CDCl3, δ = 
77.0 ppm). High resolution mass spectra (HRMS) were performed with 
micro hybrid quadrupole time of flight (Q-Tof) Mass Spectrometer (Waters) 
with Electronspray Ionization (ESI) source and MassLinx NT software. 
 
Glycosylation with trichloroacetimidate donors under batch 
conditions (General procedure A) 
To a solution of the glycosyl acceptor (1 eq) and trichloroacetimidate (1.2 
eq) in dry CH2Cl2 at room temperature and under Argon atmosphere, 
TMSOTf (0.1 eq) was added. After reaction completion (5 min), 
triethylamine was added to quench the reaction. The reaction mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt gradient). 
 
Glycosylation with thioglycoside donors under batch conditions 
(General procedure B) 
To a solution of the glycosyl acceptor (1 eq), thioglycoside (1.2 eq) and N-
iodosuccinimide (1.5 eq) in dry CH2Cl2 at room temperature and under 
Argon atmosphere, TMSOTf (0.1 eq) was added. After reaction completion 
(5 min), triethylamine was added to quench the reaction. The reaction 
mixture was concentrated in vacuo and the crude was purified by flash 
chromatography (Hexane/AcOEt gradient). 
 
Microfluidic glycosylation with trichloroacetimidate donors (General 
procedure C) 
A solution of the glycosyl acceptor (1 eq, 0.1 M) and trichloroacetimidate 
(1.2 eq, 0.12 M) in reagent grade CH2Cl2 (2 mL) was prepared (solution A). 
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A solution of TMSOTf (0.1 eq, 0.01 M) in reagent grade CH2Cl2 (5 mL) was 
prepared in a separate flask (solution B). Equal volumes (0.5 mL) of the two 
solutions were taken and injected into the microreactor (internal volume = 
13 μL) via a double syringe pump, setting the desired flow rate 
(corresponding to the reaction time, see Table 1). The mixture flowed from 
the microreactor was dropped in a CH2Cl2 solution of triethylamine to 
quench the reaction. The reaction mixture was concentrated in vacuo and 
the crude was purified by flash chromatography (Hexane/AcOEt gradient). 
 
Microfluidic glycosylation with thioglycoside donors (General 
procedure D) 
A solution of the glycosyl acceptor (1 eq, 0.1 M), thioglycoside (1.2 eq, 0.12 
M) and N-iodosuccinimide (1.5 eq, 0.15 M) in reagent grade CH2Cl2 (2 mL) 
was prepared (solution A). A solution of TMSOTf (0.1 eq, 0.01 M) in 
reagent grade CH2Cl2 (5 mL) was prepared in separate flask (solution B). 
Equal volumes (0.5 mL) of the two solutions were taken and injected into 
the microreactor (internal volume = 13 μL) via a double syringe pump, 
setting the desired flow rate (corresponding to the reaction time, see Table 
2). The mixture flowed from the microreactor was dropped in a CH2Cl2 
solution of triethylamine to quench the reaction. The reaction mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt gradient). 
 
Two-steps synthesis of trisaccharide 19 
A solution of donor 16 (76 mg, 0.12 M) and thioglycoside acceptor 17 (56 
mg, 0.1 M) in reagent grade CH2Cl2 (1 mL) was prepared (solution A, 
Scheme 3). A solution of TMSOTf (0.018 mL, 0.02 M) in reagent grade 
CH2Cl2 (5 mL) was prepared in a separate flask (solution B, Scheme 3). 
Equal volumes (0.5 mL) of the two solutions were taken and injected into 
the first microreactor (internal volume = 13 μL) via a double syringe pump, 
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setting the flow rate at 3.25 μL/min (total flow rate = 6.5 μL/min, 
corresponding to a residence time = 2 min). The reaction mixture 
(containing the disaccharide donor 18) flowed from the microreactor was 
pumped into the second microreactor together with a solution of acceptor 1 
(47 mg, 0.05 M) and NIS (34 mg, 0.075 M) in reagent grade CH2Cl2 (2 mL). 
The flow rate of the second solution was set at 6.5 μL/min (total flow rate in 
the second microreactor = 13 μL/min), in order to have an overall residence 
time = 1 min. The reaction mixture flowed from the microreactor was 
eventually quenched in a CH2Cl2 solution of triethylamine The mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt gradient), furnishing trisaccharide 19 (51%, mixture of 
anomers at the newly formed glycosidic bond) as a colourless oil. δH (400 
MHz; CDCl3) 7.61-7.05 (45H, m, HAr), 5.07 (t, 1H, t, J2,3 8.8, H2”), 5.03-4.48 
(20H, m, CH2Ph, H1’, H1), 4.38 (1H, d,  J1,2 8.0 Hz, H1”), 4.10-3.42 (17H, 
m, 2H6, 2H6’, 2H6”, H5, H5’, H5”, H4, H4’, H4”, H3, H3’, H3”, H2, H2’), 3.36 
(3H, s, OCH3-α), 3.31 (s, 3H, OCH3-β), 1.87 (s, 3H, CH3-Ac); δC (100 MHz; 
CDCl3) 128.4-127.4, 101.0, 98.0, 97.1, 78.1, 75.7, 75.4, 75.3, 75.0, 74.7, 
73.4, 73.0, 72.3, 70.6, 69.8, 68.9, 67.8, 65.7, 55.1, 20.9; HRMS (Q-Tof) 
[M+Na]+ m/z calc 1393.6076 for C84H90O17Na, found 1393.6066. 
 
Electronic Supplementary Information (ESI) available: Experimental 
procedures for the synthesis of compounds 1-9 and 16-18, copies of 1H-
NMR spectra of compounds 10-15 and 1H-NMR and 13C-NMR spectra of 
compounds 18 and 19.  
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Synthesis of glycosyl acceptors 
 
Methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside (1) 
 
 
 
To a cooled solution (0°C) of methyl α-D-glucopyranoside (2.50 g, 12.88 
mmol) and imidazole (2.63 g, 38.64 mmol) in DMF (20 mL), TIPSCl (3.03 
mL, 14.17 mmol) was added dropwise over a period of 15 minutes. After 17 
h at rt, the reaction mixture was concentrated in vacuo, then the crude was 
diluted with water (100 mL) and extracted with CH2Cl2 (3 x 60 mL). The 
combined organic layers were washed with brine, dried over Na2SO4, 
concentrated in vacuo, and dried under high vacuum. To a solution of crude 
S1 and BnBr (7.60 mL, 64.40 mmol) in DMF (100 mL) NaH (1.46 g, 64.40 
mmol) was slowly added. After 16 h at rt the reaction mixture was carefully 
quenched with MeOH (100 mL). The reaction mixture was concentrated in 
vacuo, then the crude was diluted with H2O and extracted with CH2Cl2 (3 x 
100 mL). The combined organic layers were washed with brine, dried over 
Na2SO4, and concentrated in vacuo. To a solution of crude S2 in dry THF 
(25 mL), TBAF 1.0M in THF (25.8 mL, 25.76 mmol) was added. The 
reaction mixture was stirred at rt for 16 h, diluted with H2O, and extracted 
with CH2Cl2 (3x100 mL). The combined organic layers were washed with 
brine, dried over Na2SO4, concentrated in vacuo, and purified by flash 
chromatography (Hexane:EtOAc 6:4) to obtain compound 1 as a white solid 
(4.85 g, 81%, over 3 steps). 
The spectroscopic data of acceptor 1 were in agreement with those 
previously reported.1 
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Methyl 4,6-O-benzylidene-α-D-glucopyranoside (S3) 
 
 
 
To a solution of methyl α-D-glucopyranoside (5.00 g, 25.7 mmol) and 
PhCH(OMe)2 (11.6 mL, 77.1 mmol) in CH3CN (85 mL), a catalytic amount 
of camphorsulfonic acid (pH = 2) was added. After 48 h the reaction was 
neutralized with TEA and concentrated in vacuo. The crude was purified by 
flash chromatography (Hexane:AcOEt 2:8) to obtain the S3 (6.25 g, 86%). 
The spectroscopic data of S3 were in agreement with those previously 
reported.2 
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Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (S4) 
 
 
 
To a solution of S3 (2.00 g, 7.08 mmol) and BnBr (2.1 mL, 17.7 mmol) in 
DMF (45 mL), NaH (0.37 g, 15.6 mmol) was carefully added. After 1 h the 
reaction mixture was carefully quenched with MeOH (20 mL). The reaction 
mixture was concentrated in vacuo, then the crude was diluted with H2O 
and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, concentrated in vacuo, and purified 
by flash chromatography (Hexane:EtOAc 8:2) to obtain S4 as a white solid 
(2.86 g, 87%). 
The spectroscopic data of S4 were in agreement with those previously 
reported.2 
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Methyl 2,3,6-tri-O-benzyl-α-D-glucopyranoside (2) 
 
 
 
To a cooled solution (0°C) of S4 (2.86 g, 6.18 mmol) and Et3SiH (4.93 mL, 
30.9 mmol) in dry CH2Cl2 (40 mL), trifluoroacetic acid (2.35 mL, 30.9 mmol) 
was slowly added (15 min). After 3.5 h the mixture was diluted with CH2Cl2 
and neutralized with a satd aqueous solution of NaHCO3. The two phases 
were separated, and the organic layer was washed with a satd aqueous 
solution of NaHCO3 and brine, dried over Na2SO4 and concentrated in 
vacuo. The crude was purified by flash chromatography (Hexane:EtOAc 
8:2) to obtain compound 2 as a colourless oil (2.49 g, 87%). 
The spectroscopic data of 2 were in agreement with those previously 
reported.3 
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Methyl 2-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (3) 
 
 
 
To a solution of S3 (2.00 g, 7.08 mmol) in a mixture THF:DMF 10:1 (77 
mL), NaH (0.34 g, 14.23 mmol) was added. After 1 h NiCl2 (0.92 g, 7.08 
mmol) was added. After 1 h BnBr (0.92 mL, 7.08 mmol) was added. The 
reaction mixture was allowed to react for 48 h, thereafter it was quenched 
by addition of H2O and 5 drops of AcOH. The solvents were removed in 
vacuo, and the crude residue was diluted with H2O and extracted with a 
CH2Cl2/CHCl3 mixture (3 x 50 mL). The combined organic layers were 
washed with H2O, a satd aqueous solution of NaHCO3 and brine, dried over 
Na2SO4, concentrated in vacuo, and purified by flash chromatography 
(Hexane:EtOAc 8:2→7:3) to obtain compound 3 as a white solid (1.14 g, 
43%). 
The spectroscopic data of compound 3 were in agreement with those 
previously reported.4 
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Synthesis of glycosyl donors: Trichloroacetimidates 
 
2,3,4,6-tetra-O-benzyl-D-glucopyranosyl trichloroacetimidate (4) 
 
 
 
To a solution of 2,3,4,6-tetra-O-benzyl-D-glucopyranose (1.00 g, 1.85 
mmol) and Cl3CCN (1.85 mL, 18.5 mmol) in dry CH2Cl2 (20 mL), a catalytic 
amount of DBU was added. After 2 h the reaction mixture was concentrated 
in vacuo and purified by flash chromatography (Hexane:EtOAc 9:1→8:2 + 
1% TEA) to obtain compound 4 as a white solid (1.22 g, 96%, αβ = 18:1). 
The spectroscopic data of donor 4 were in agreement with those previously 
reported.5 
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Allyl 4,6-O-benzylidene-D-glucopyranoside (S6) 
 
 
 
To a solution of D-glucopyranose (1.00 g, 5.55 mmol) in allyl alcohol (35 
mL), TMSCl (7.00 mL, 55.5 mmol) was added. After 12 h the allyl alcohol 
was removed in vacuo. The crude residue was diluted with toluene and 
concentrated in vacuo two times, and dried under high vacuum. To a 
solution of crude S5 and PhCH(OMe)2 (1.25 mL, 8.33 mmol) in CH3CN (35 
mL), p-TsOH (0.11 g, 0.56 mmol) was added. After 5 h the reaction was 
neutralized with TEA and concentrated in vacuo. The crude residue was 
purified by flash chromatography (Hexane:EtOAc 1:1) to obtain S6 as a 
colourless oil (1.44 g, 85%). 
The spectroscopic data of S6 were in agreement with those previously 
reported.6 
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Allyl 2,3-di-O-benzyl-4,6-O-benzylidene-D-glucopyranoside (S7) 
 
 
 
To a solution of S6 (1.44 g, 4.70 mmol) and BnBr (1.40 mL, 11.75 mmol) in 
DMF (40 mL), NaH (0.25 g, 10.34 mmol) was slowly added. After 3 h the 
reaction mixture was carefully quenched with MeOH (10 mL). The reaction 
mixture was concentrated in vacuo, then the crude residue was diluted with 
H2O and extracted with CH2Cl2 (3 x 20 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, concentrated in vacuo, and 
purified by flash chromatography (Hexane:EtOAc 9:1) to obtain S7 as a 
white solid (2.01 g, 87%). 
The spectroscopic data of S7 were in agreement with those previously 
reported.7 
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2,3-di-O-Benzyl-4,6-O-benzylidene-D-glucopyranose (S9) 
 
 
 
To a solution of S7 (1.00 g, 2.05 mmol) in DMF (20 mL), tBuOK (0.46 g, 
4.10 mmol) was added and the solution was warmed to 60°C. After 0.5 h 
the reaction mixture was cooled at room temperature and quenched by 
addition of 5% aqueous HCl, then the DMF was removed in vacuo. The 
crude residue was diluted with diethyl ether (30 mL) and washed with 5% 
aqueous HCl (20 mL). The aqueous layer was washed with diethyl ether (2 
x 20 mL) and the combined organic layers were dried over Na2SO4, 
concentrated in vacuo, and dried under high vacuum. To a solution of crude 
S8 in THF:H2O 4:1 (20 mL), I2 (1.04 g, 4.10 mmol) was added. After 15 
minutes, the reaction was quenched by addition of a satd aqueous solution 
of Na2S2O3 (20 mL) and extracted with AcOEt (2 x 20 mL). The combined 
organic layers were dried over Na2SO4, concentrated in vacuo, and purified 
by flash chromatography (Hexane:EtOAc 7:3) to obtain S9 as a colourless 
oil (0.79 g, 86%). 
The spectroscopic data of S9 were in agreement with those previously 
reported.8 
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2,3-di-O-Benzyl-4,6-O-benzylidene-D-glucopyranosyl 
trichloroacetimidate (5) 
 
 
 
To a solution of S9 (0.79 g, 1.77 mmol) and Cl3CCN (1.8 mL, 17.7 mmol) in 
dry CH2Cl2 (20 mL), a catalytic amount of DBU was added. After 0.5 h the 
reaction mixture was concentrated in vacuo and purified by flash 
chromatography (Hexane:EtOAc 9:1 + 1% TEA) to obtain compound 5 as a 
white solid (0.81 g, 77%, αβ = 5:1). 
The spectroscopic data of donor 5 were in agreement with those previously 
reported.9 
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Synthesis of glycosyl donors: Thioglycosides 
 
Ethyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside (S10) 
 
 
 
To a cooled solution (0°C) of β-D-pentaacetylglucose (5.00 g, 12.85 mmol) 
and ethanethiol (4.73 mL, 64.05 mmol) in dry CH2Cl2 (80 mL), BF3
.OEt2 
(2.44 mL, 19.22 mmol) was slowly added. After 20 h the reaction was 
neutralized with TEA and the solvent was removed in vacuo. The crude 
residue was purified by flash chromatography (Hexane:EtOAc 7:3) to obtain 
S10 as a white solid (3.80 g, 76%). 
The spectroscopic data of S10 were in agreement with those previously 
reported.10 
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Ethyl 1-thio-β-D-glucopyranoside (S11) 
 
 
 
To a solution of S10 (3.80 g, 9.68 mmol) in dry MeOH (90 mL), NaOMe 
0.4M in MeOH (3.63 mL, 1.45 mmol) was added. After 15 min the reaction 
was diluted with MeOH and neutralized with AMBERLITE® resin (H+ form). 
The mixture was filtered and the solvent was removed in vacuo, obtaining 
S11 as a white solid (2.17 g, qu). 
The spectroscopic data of S11 were in agreement with those previously 
reported.11 
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Ethyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (6) 
 
 
 
To a solution of S11 (0.59 g, 2.63 mmol) and BnBr (1.41 mL, 11.84 mmol) 
in DMF (17.5 mL), NaH (0.25 g, 11.05 mmol) was slowly added. After 6 h 
the reaction mixture was carefully quenched with MeOH (10 mL). The 
reaction mixture was concentrated in vacuo, then the crude residue was 
diluted with H2O and extracted with CH2Cl2 (3 x 20 mL). The combined 
organic layers were washed with brine, dried over Na2SO4, concentrated in 
vacuo, and purified by flash chromatography (Hexane:EtOAc 9:1) to obtain 
compound 6 as a white solid (0.90 g, 80%). 
The spectroscopic data of 6 were in agreement with those previously 
reported.12 
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Ethyl 4,6-O-benzylidene-1-thio-β-D-glucopyranoside (S12) 
 
 
 
To a solution of S11 (1.14 g, 5.09 mmol) and PhCH(OMe)2 (2.30 mL, 15.27 
mmol) in CH3CN (35 mL), a catalytic amount of camphorsulfonic acid (pH = 
2) was added. After 2 h the reaction was neutralized with TEA and 
concentrated in vacuo. The crude was purified by flash chromatography 
(Hexane:AcOEt 1:1) to obtain S12 (1.20 g, 76%). 
The spectroscopic data of S12 were in agreement with those previously 
reported.13 
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Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-β-D-glucopyranoside 
(8) 
 
 
 
To a solution of S12 (0.60 g, 1.92 mmol) and BnBr (0.57 mL, 4.80 mmol) in 
DMF (20 mL), NaH (0.10 g, 4.22 mmol) was slowly added. After 1 h the 
reaction mixture was carefully quenched with MeOH (5 mL). The reaction 
mixture was concentrated in vacuo, then the crude residue was diluted with 
H2O and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers 
were washed with brine, dried over Na2SO4, concentrated in vacuo, and 
purified by flash chromatography (Hexane:EtOAc 9:1) to obtain compound 
8 as a white solid (0.76 g, 82%). 
The spectroscopic data of 8 were in agreement with those previously 
reported.14 
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4-Methylphenyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside 
(S13) 
 
 
 
To a cooled solution (0°C) of β-D-pentaacetylglucose (5.00 g, 12.85 mmol) 
and 4-methylbenzenethiol (7.90 g, 63.71 mmol) in dry CH2Cl2, BF3
.OEt2 (2.5 
mL, 19.72 mmol) was slowly added. After 22 h the reaction was neutralized 
with TEA and the solvent was removed in vacuo. The crude residue was 
purified by flash chromatography (Hexane:EtOAc 7:3) to obtain S13 as a 
white solid (5.29 g, 91%). 
The spectroscopic data of S13 were in agreement with those previously 
reported.15 
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4-Methylphenyl 1-thio-β-D-glucopyranoside (S14) 
 
 
 
To a solution of S13 (4.00 g, 8.80 mmol) in dry MeOH (60 mL), NaOMe 
0.4M in MeOH (3.30 mL, 1.32 mmol) was added. After 15 min the reaction 
mixture was diluted with MeOH and neutralized with AMBERLITE® resin 
(H+ form). The mixture was filtered and the solvent was removed in vacuo, 
obtaining S14 as a white solid (2.52 g, qu). 
The spectroscopic data of S14 were in agreement with those previously 
reported.16 
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4-Methylphenyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside (7) 
 
 
 
To a solution of S14 (1.35 g, 4.71 mmol) and BnBr (2.54 mL, 21.37 mmol) 
in DMF (47 mL), NaH (0.83 g, 19.94 mmol) was slowly added. After 15 h 
the reaction mixture was carefully quenched by addition of MeOH (10 mL). 
The reaction mixture was concentrated in vacuo, then the crude residue 
was diluted with H2O and extracted with CH2Cl2 (3 x 20 mL). The combined 
organic layers were washed with brine, dried over Na2SO4, concentrated in 
vacuo, and purified by flash chromatography (Hexane:EtOAc 9:1) to obtain 
compound 7 as a white solid (2.49 g, 82%). 
The spectroscopic data of 7 were in agreement with those previously 
reported.16  
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4-Methylphenyl 4,6-O-benzylidene-1-thio-β-D-glucopyranoside (S15) 
 
 
 
To a solution of S14 (1.19 g, 4.10 mmol) and PhCH(OMe)2 (1.85 mL, 12.30 
mmol) in CH3CN (30 mL), a catalytic amount of camphorsulfonic acid (pH = 
2) was added. After 23 h the reaction mixture was neutralized with TEA and 
concentrated in vacuo. The crude residue was purified by flash 
chromatography (Hexane:AcOEt 1:1) to obtain S15 (1.31 g, 85%). 
The spectroscopic data of S15 were in agreement with those previously 
reported.17 
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4-Methylphenyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-β-D-
glucopyranoside (9) 
 
 
 
To a solution of S15 (1.31 g, 3.49 mmol) and BnBr (1.04 mL, 8.72 mmol) in 
DMF (35 mL), NaH (0.18 g, 7.67 mmol) was slowly added. After 1 h the 
reaction mixture was carefully quenched by addition of MeOH (10 mL). The 
reaction mixture was concentrated in vacuo, then the crude residue was 
diluted with H2O and extracted with CH2Cl2 (3 x 15 mL). The combined 
organic layers were washed with brine, dried over Na2SO4, concentrated in 
vacuo and purified by flash chromatography (Hexane:EtOAc 9:1) to obtain 
thioglycoside 9 as a white solid (1.75 g, 95%). 
The spectroscopic data of 9 were in agreement with those previously 
reported.17 
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Glycosylation reactions 
 
Glycosylation with trichloroacetimidate donors under batch 
conditions (General procedure A) 
To a solution of the glycosyl acceptor (1 eq) and trichloroacetimidate (1.2 
eq) in dry CH2Cl2 at room temperature and under Argon atmosphere, 
TMSOTf (0.1 eq) was added. After reaction completion (5 min), 
triethylamine was added to quench the reaction. The reaction mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt gradient). 
 
Glycosylation with thioglycoside donors under batch conditions 
(General procedure B) 
To a solution of the glycosyl acceptor (1 eq), thioglycoside (1.2 eq) and N-
iodosuccinimide (1.5 eq) in dry CH2Cl2 at room temperature and under 
Argon atmosphere, TMSOTf (0.1 eq) was added. After reaction completion 
(5 min), triethylamine was added to quench the reaction. The reaction 
mixture was concentrated in vacuo and the crude was purified by flash 
chromatography (Hexane/AcOEt gradient). 
 
Microfluidic glycosylation with trichloroacetimidate donors (General 
procedure C) 
A solution of the glycosyl acceptor (1 eq, 0.1 M) and trichloroacetimidate 
(1.2 eq, 0.12 M) in reagent grade CH2Cl2 (2 mL) was prepared (solution A). 
A solution of TMSOTf (0.1 eq, 0.01 M) in reagent grade CH2Cl2 (5 mL) was 
prepared in a separate flask (solution B). Equal volumes (0.5 mL) of the two 
solutions were taken and injected into the microreactor (internal volume = 
13 μL) via a double syringe pump, setting the desired flow rate 
(corresponding to the reaction time, see Table 1). The mixture flowed from 
the microreactor was dropped in a CH2Cl2 solution of triethylamine to 
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quench the reaction. The reaction mixture was concentrated in vacuo and 
the crude was purified by flash chromatography (Hexane/AcOEt gradient). 
 
Microfluidic glycosylation with thioglycoside donors (General 
procedure D) 
A solution of the glycosyl acceptor (1 eq, 0.1 M), thioglycoside (1.2 eq, 0.12 
M) and N-iodosuccinimide (1.5 eq, 0.15 M) in reagent grade CH2Cl2 (2 mL) 
was prepared (solution A). A solution of TMSOTf (0.1 eq, 0.01 M) in 
reagent grade CH2Cl2 (5 mL) was prepared in separate flask (solution B). 
Equal volumes (0.5 mL) of the two solutions were taken and injected into 
the microreactor (internal volume = 13 μL) via a double syringe pump, 
setting the desired flow rate (corresponding to the reaction time, see Table 
2). The mixture flowed from the microreactor was dropped in a CH2Cl2 
solution of triethylamine to quench the reaction. The reaction mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt gradient). 
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Glycosylations with Trichloroacetimidates 
 
Table 1, Entry 1 
Compounds 1 (50 mg, 0.108 mmol) and 4 (89 mg, 0.130 mmol) were 
treated as described in the General Procedure A. Product 10 was obtained 
in 66% yield (70 mg, 0.071 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18 
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 2 
Compounds 1 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 2.6 L/min. Product 10 was obtained in 81% 
yield (40 mg, 0.041 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 3 
Compounds 1 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 10 was obtained in 95% 
yield (47 mg, 0.048 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
 83 
 
Table 1, Entry 4 
Compounds 1 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min and the microreactor was putted in a 
cooled bath (0°C). Product 10 was obtained in 99% yield (49 mg, 0.049 
mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 5 
Compounds 1 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min and the microreactor was cooled at -
20°C in a cooling bath. Product 10 was obtained in 26% yield (13 mg, 0.013 
mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 6 
Compounds 2 (50 mg, 0.108 mmol) and 4 (89 mg, 0.130 mmol) were 
treated as described in the General Procedure A. Product 11 was obtained 
in 28% yield (30 mg, 0.030 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 7 
Compounds 2 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 2.6 L/min. Product 11 was obtained in 50% 
yield (25 mg, 0.025 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 8 
Compounds 2 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 11 was obtained in 77% 
yield (38 mg, 0.039 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 9 
Compounds 3 (50 mg, 0.134 mmol) and 4 (110 mg, 0.161 mmol) were 
treated as described in the General Procedure A. Product 12 was obtained 
in 58% yield (70 mg, 0.078 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19 
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 10 
Compounds 3 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 2.6 L/min. Product 12 was obtained in 50% 
yield (22 mg, 0.025 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 11 
Compounds 3 and 4 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 12 was obtained in 85% 
yield (38 mg, 0.043 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 12 
Compounds 1 (50 mg, 0.108 mmol) and 5 (77 mg, 0.130 mmol) were 
treated as described in the General Procedure A. Product 13 was obtained 
in 62% yield (60 mg, 0.067 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20 
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 13 
Compounds 1 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 13 was obtained in 92% 
yield (41 mg, 0.046 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 14 
Compounds 1 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 26 L/min. Product 13 was obtained in 93% 
yield (42 mg, 0.047 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 15 
Compounds 2 (50 mg, 0.108 mmol) and 5 (77 mg, 0.130 mmol) were 
treated as described in the General Procedure A. Product 14 was obtained 
in 71% yield (69 mg, 0.077 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 16 
Compounds 2 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 14 was obtained in 62% 
yield (28 mg, 0.031 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 17 
Compounds 2 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 26 L/min. Product 14 was obtained in 65% 
yield (29 mg, 0.033 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 18 
Compounds 3 (50 mg, 0.134 mmol) and 5 (95 mg, 0.161 mmol) were 
treated as described in the General Procedure A. Product 15 was obtained 
in 56% yield (60 mg, 0.075 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21 
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 19 
Compounds 3 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 13 L/min. Product 15 was obtained in 60% 
yield (24 mg, 0.030 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 1, Entry 20 
Compounds 3 and 5 were treated as described in the General Procedure 
C. The flow rate was set to 26 L/min. Product 15 was obtained in 57% 
yield (23 mg, 0.029 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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Glycosylations with Thioglycosides 
 
Table 2, Entry 1 
Compounds 1 (50 mg, 0.108 mmol) and 6 (76 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 10 was obtained 
in 71% yield (76 mg, 0.077 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 2 
Compounds 1 and 6 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 10 was obtained in 81% 
yield (40 mg, 0.041 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 3 
Compounds 2 (50 mg, 0.108 mmol) and 6 (76 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 11 was obtained 
in 69% yield (74 mg, 0.075 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 4 
Compounds 2 and 6 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 11 was obtained in 81% 
yield (34 mg, 0.034 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 5 
Compounds 3 (50 mg, 0.134 mmol) and 6 (94 mg, 0.161 mmol) were 
treated as described in the General Procedure B. Product 12 was obtained 
in 90% yield (87 mg, 0.097 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 6 
Compounds 3 and 6 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 12 was obtained in 76% 
yield (34 mg, 0.038 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
 106 
 
Table 2, Entry 7 
Compounds 1 (50 mg, 0.108 mmol) and 8 (64 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 13 was obtained 
in 80% yield (77 mg, 0.086 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 8 
Compounds 1 and 8 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 13 was obtained in 70% 
yield (31 mg, 0.035 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 9 
Compounds 2 (50 mg, 0.108 mmol) and 8 (64 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 14 was obtained 
in 55% yield (53 mg, 0.059 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 10 
Compounds 2 and 8 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 14 was obtained in 56% 
yield (25 mg, 0.028 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 11 
Compounds 3 (50 mg, 0.134 mmol) and 8 (79 mg, 0.161 mmol) were 
treated as described in the General Procedure B. Product 15 was obtained 
in 88% yield (95 mg, 0.118 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 12 
Compounds 3 and 8 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 15 was obtained in 60% 
yield (24 mg, 0.030 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 13 
Compounds 1 (50 mg, 0.108 mmol) and 7 (84 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 10 was obtained 
in 68% yield (72 mg, 0.073 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 14 
Compounds 1 and 7 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 10 was obtained in 81% 
yield (40 mg, 0.041 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.18  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 15 
Compounds 3 (50 mg, 0.134 mmol) and 7 (104 mg, 0.161 mmol) were 
treated as described in the General Procedure B. Product 12 was obtained 
in 86% yield (103 mg, 0.115 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 16 
Compounds 3 and 7 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 12 was obtained in 69% 
yield (31 mg, 0.035 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.19  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 17 
Compounds 1 (50 mg, 0.108 mmol) and 9 (72 mg, 0.130 mmol) were 
treated as described in the General Procedure B. Product 13 was obtained 
in 65% yield (63 mg, 0.070 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 18 
Compounds 1 and 9 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 13 was obtained in 80% 
yield (36 mg, 0.040 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.20  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 19 
Compounds 3 (50 mg, 0.134 mmol) and 9 (89 mg, 0.161 mmol) were 
treated as described in the General Procedure B. Product 15 was obtained 
in 88% yield (95 mg, 0.118 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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Table 2, Entry 20 
Compounds 3 and 9 were treated as described in the General Procedure 
D. The flow rate was set to 13 L/min. Product 15 was obtained in 75% 
yield (31 mg, 0.038 mmol). 
The spectroscopic data were in agreement with those reported in the 
literature.21  
 
 
1
H NMR (400 MHz, CDCl3) 
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4-Methylphenyl 2,3,4-tri-O-benzyl-1-thio-β-D-glucopyranoside (17) 
 
 
 
To a solution of 9 (0.50 g, 0.90 mmol) in BH3
.THF complex (1M in THF, 
4.50 mL, 4.50 mmol), Cu(OTf)2 (0.016 g, 0.045 mmol) was added. After 6 h 
the reaction was cooled to 0°C and neutralized with TEA (0.13 mL, 0.90 
mmol) and MeOH (1.6 mL). The reaction mixture was concentrated in 
vacuo and purified by flash chromatography (Hexane:AcOEt 8:2) to obtain 
compound 17 as a white solid (0.48 g, 96%). 
The spectroscopic data of 17 were in agreement with those previously 
reported.22 
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3,4,6-tri-O-benzyl-1,2-O-(1-methoxyethylidene)-α-D-glucopyranoside 
(S17) 
 
 
 
To a solution of 3,4,6-tri-O-acetyl-1,2-O-(1-methoxyethylidene)-α-D-
glucopyranoside (2.00 g, 5.52 mmol) in dry MeOH (50 mL), NaOMe 0.4M in 
MeOH (2.07 mL, 0.83 mmol) was added. After 30 min the reaction mixture 
was diluted with MeOH and neutralized with AMBERLITE® resin (H+ form). 
The mixture was filtered and the solvent was removed in vacuo, obtaining 
compound S16 as a white solid (1.30 g, quant). To a solution of S16 (1.30 
g, 5.52 mmol) and BnBr (3.28 mL, 27.6 mmol) in DMF (50 mL), NaH (0.66 
g, 27.6 mmol) was slowly added. After 3 h the reaction mixture was 
carefully quenched by addition of MeOH (10 mL). The reaction mixture was 
concentrated in vacuo, then the crude residue was diluted with H2O and 
extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were 
washed with brine, dried over Na2SO4, concentrated in vacuo, and purified 
by flash chromatography (Hexane:EtOAc 8:2→7:3 + 1% TEA) to obtain the 
S17 as a colourless oil (2.23 g, 82%). 
The spectroscopic data of S17 were in agreement with those previously 
reported.23 
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2-O-Acetyl-3,4,6-tri-O-benzyl-D-glucopyranose (S18) 
 
 
 
To a cooled solution (0°C) of S17 (0.66 g, 1.30 mmol) in acetone:H2O 7:3 
(10 mL), p-TsOH (0.034 g, 0.39 mmol) was added. After 2 h the reaction 
mixture was neutralized with TEA and concentrated in vacuo. The crude 
residue was purified by flash chromatography (Hexane:AcOEt 7:3) to obtain 
S18 (0.54 g, 85%). 
The spectroscopic data of S18 were in agreement with those previously 
reported.24 
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2-O-acetyl-3,4,6-tri-O-benzyl-α-D-glucopyranosyl trichloroacetimidate 
(16) 
 
 
 
To a solution of S18 (0.54 g, 1.10 mmol) and Cl3CCN (1.10 mL, 11.0 mmol) 
in dry CH2Cl2 (11 mL), a catalytic amount of DBU was added. After 1 h, the 
reaction mixture was concentrated in vacuo and purified by flash 
chromatography (Hexane:EtOAc 8:2 + 1% TEA) to obtain donor 16 as a 
colourless oil (0.64 g, 91%, only ). 
The spectroscopic data of donor 16 were in agreement with those 
previously reported.25 
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Microfluidic glycosylation between 16 and 17 
 
 
 
A solution of the glycosyl acceptor 17 (56 mg, 0.1 M) and 
trichloroacetimidate 16 (76 mg, 0.12 M) in reagent grade CH2Cl2 (1 mL) 
was prepared (solution A). A solution of TMSOTf (18 L, 0.02 M) in reagent 
grade CH2Cl2 (5 mL) was prepared in a separate flask (solution B). Equal 
volumes (0.5 mL) of the two solutions were taken and injected into the 
microreactor (internal volume = 13 μL) via a double syringe pump, setting 
the flow rate at 3.25 μL/min (total flow rate = 6.5 L/min, corresponding to a 
residence time = 2 min). The mixture flowed from the microreactor was 
dropped in a CH2Cl2 solution of triethylamine to quench the reaction. The 
reaction mixture was concentrated in vacuo and the crude was purified by 
flash chromatography (Hexane/AcOEt 9:1→8:2) to obtain the disaccharide 
18 as white solid (46 mg, 90%). 
 
1H-NMR (400 MHz, CDCl3) δ 7.60-7.00 (34H, m, HAr), 5.06 (1H, t, J2,3 8.0 
Hz, H2’), 4.93-4.54 (13H, m, CH2Ph, H1), 4.51 (1H, d, J1,2 8.1 Hz, H1’), 4.14 
(1H, d, H6), 3.76-3.61 (7H, m, 2H6’, H6, H4’, H4, H3’, H3), 3.55-3.42 (3H, 
m, H5, H5’, H2), 2.33 (3H, s, CH3-Tol), 1.89 (3H, s, CH3-Ac) 
13C-NMR (100 MHz, CDCl3) δ 132.3, 131.7, 130.0, 129.8, 128.4, 128.4, 
128.4, 128.2, 128.0, 127.9, 127.8, 127.8, 127.8, 127.7, 127.6, 100.9, 87.8, 
 125 
 
86.6, 83.2, 80.7, 78.8, 78.1, 77.8, 75.7, 75.5, 75.3, 75.3, 75.0, 74.9, 73.6, 
73.1, 68.8, 67.9 
HRMS (Q-Tof) [M+Na]+ m/z calcd for C63H66O11SNa 1053.4223, found 
1053.4486 
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13
C NMR (100 MHz, CDCl3) 
1
H NMR (400 MHz, CDCl3) 
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Two-steps synthesis of trisaccharide 19 
 
 
 
A solution of donor 16 (76 mg, 0.12 M) and thioglycoside acceptor 17 (56 
mg, 0.1 M) in reagent grade CH2Cl2 (1 mL) was prepared (solution A, 
Scheme 3). A solution of TMSOTf (0.018 mL, 0.02 M) in reagent grade 
CH2Cl2 (5 mL) was prepared in a separate flask (solution B, Scheme 3). 
Equal volumes (0.5 mL) of the two solutions were taken and injected into 
the first microreactor (internal volume = 13 μL) via a double syringe pump, 
setting the flow rate at 3.25 μL/min (total flow rate = 6.5 L/min, 
corresponding to a residence time = 2 min). The reaction mixture 
(containing the disaccharide donor 18) flowed from the microreactor was 
pumped into the second microreactor together with a solution of acceptor 1 
(47 mg, 0.05 M) and NIS (34 mg, 0.075 M) in reagent grade CH2Cl2 (2 mL). 
The flow rate of the second solution was set at 6.5 μL/min (total flow rate in 
the second microreactor = 13 μL/min), in order to have an overall residence 
time = 1 min. The reaction mixture flowed from the microreactor was 
eventually quenched in a CH2Cl2 solution of triethylamine The mixture was 
concentrated in vacuo and the crude was purified by flash chromatography 
(Hexane/AcOEt 8:2→7:3), furnishing trisaccharide 19 (35 mg, 51%, mixture 
of anomers at the newly formed glycosidic bond) as a colourless oil. 
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1H-NMR (400 MHz, CDCl3) δ 7.61-7.05 (45H, m, HAr), 5.07 (t, 1H, t, J2,3 8.8, 
H2”), 5.03-4.48 (20H, m, CH2Ph, H1’, H1), 4.38 (1H, d,  J1,2 8.0 Hz, H1”), 
4.10-3.42 (17H, m, 2H6, 2H6’, 2H6”, H5, H5’, H5”, H4, H4’, H4”, H3, H3’, 
H3”, H2, H2’), 3.36 (3H, s, OCH3-α), 3.31 (s, 3H, OCH3-β), 1.87 (s, 3H, 
CH3-Ac) 
13C-NMR (100 MHz, CDCl3) δ 128.4-127.4, 101.0, 98.0, 97.1, 78.1, 75.7, 
75.4, 75.3, 75.0, 74.7, 73.4, 73.0, 72.3, 70.6, 69.8, 68.9, 67.8, 65.7, 55.1, 
20.9 
HRMS (Q-Tof) [M+Na]+ m/z calcd for C84H90O17Na 1393.6076, found 
1393.6066 
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13
C NMR (100 MHz, CDCl3) 
1
H NMR (400 MHz, CDCl3) 
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MRT and Glycosyl phosphodiesters 
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1 Phosphoglycans: structural diversity and chemical 
synthesis 
 
The most common type of inter-monomeric linkage in carbohydrate-
containing polymers is the glycosidic linkage between monosaccharides. 
However, a different type of intersaccharide linkage is also widespread: a 
phosphodiester linkage formed by a glycosyl phosphate unit and an 
hydroxyl group of another monosaccharide. This type of linkage is found in 
many polymers (commonly named “phosphoglycans”) of the cell wall or 
capsule of bacteria and yeasts. It is also present in glycan chain of some 
glycoproteins in animals. In many cases, the glycosyl phosphate units 
participating in the formation of phosphodiester linkages are constituents of 
the antigenic determinants defining the immunological specificity. 
The importance of phosphoglycans as immunologically active components 
of the cell wall and/or capsule of numerous pathogenic microorganisms 
upholds the need to develop potential routes for the chemical preparation of 
these biopolymers. The synthesis of glycosyl phosphosaccharides 
(anomeric phosphodiesters in which phosphorus is linked to one 
monosaccharide through the hemiacetal hydroxyl group at C-1 and to 
another through an alcoholic hydroxyl group) becomes a primary task. 
Chemical formation of glycosyl phosphosaccharides is complicated as both 
the correct stereochemistry at C-1 and the lability of anomeric 
phosphodiester linkages must have to take into consideration. 
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1.1 Chemical synthesis of glycosyl phosphosaccharides 
For the preparation of glycosyl phosphosaccharides five basic synthetic 
methodologies have been reported:1 
I. Phosphodiester approach; 
II. Phosphotriester approach; 
III. Phosphorus (or phosphate) triester (including phosphoramidite and 
phosphorichlorite version) approach; 
IV. Hydrogenphosphonate (H-phosphonate) approach; 
V. Approach based on glycosylation reaction. 
The five methods mentioned are systematically represented in Scheme 16. 
Approaches I and II are based on P(V) chemistry, while approaches III and 
IV on P(III) chemistry. 
 
Scheme 16. Schematic representation of methods I-IV in phosphodiester synthesis 
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The first four methods (Scheme 16) were originally designed for nucleotide 
chemistry: they involved the condensation of various P-containing glycosyl 
components (electrophiles) with alcohol monosaccharide derivatives 
(nucleophiles). The last one (approach V) is a solely carbohydrate method 
as it involves the reaction of a glycosyl donor (electrophile) with a P-
containing glycosyl acceptor (nucleophile). 
Among all these basic synthetic methodologies employed for the 
preparation of glycosyl phosphosaccharides, the approaches based on 
P(III) chemistry are currently the most widespread techniques: in particular, 
the Hydrogenphosphonate approach is the most used, also in our 
laboratory. 
 
1.2 Hydrogenphosphonate methods 
In the mid-1980s the first applications of H-phosphonate method in 
carbohydrate chemistry were described by van Boom’s group2 and by 
Nikolaev’s group.3 
In the glycosyl hydrogenphosphonate (H-phosphonate) method glycosyl H-
phosphonate derivative B is coupled with a monohydroxyl component C in 
the presence of a condensing agent to produce a phosphorous (H-
phosphonic) diester D. The intermediate D is then oxidized to form the 
targeted glycosyl phosphodiester E (Scheme 17). 
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Scheme 17. H-phosphonate approach 
 
The most frequently used condensing reagent is trimethylacetyl chloride. 
The oxidation reaction is normally performed in situ using iodine in aqueos 
pyridine (in general at low temperature, e.g.        -40°C).  
Glycosyl H-phosphonate B can be effectively prepared from the 
corresponding α-hemiacetal derivative A using either tri-
imidazolylphosphine (made from PCl3, imidazole and Et3N) or 2-chloro-
1,2,3-benzodioxaphosphorin-4-one (commonly named salicyl 
chlorophosphite). 
It has been reported that the -hemiacetal derivative F can be used to 
form pure -glycosyl H-phosphonate B on reaction with either 
salycilchlorophosphite in pyridine or H3PO3, suggesting that the reactivity of 
the α-hemiacetal constituent towards these reagents is markedly higher 
than that of the β-hemiacetal. Alternatively, αβ-glycosyl H-phosphonate G 
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can be converted into α-glycosyl H-phosphonate B on treatment with 
H3PO3 in acetonitrile. 
The H-phosphonate method appears to be the most efficient for the 
preparation of glycosyl phosphosaccharides linked through either primary 
or secondary hydroxyl groups and containing monosaccharides of diverse 
composition. The main characteristics of this approach are high 
effectiveness and high reaction rate for all the three steps involved: glycosyl 
H-phosphonate preparation, condensation with a mono-hydroxyl 
component and final oxidation (the latter two steps are normally performed 
in situ). Another advantage is that it does not require a P-protecting group. 
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1 Neisseria Meningitidis type X 
 
The Gram-negative organism Neisseria Meningitidis is the major cause of 
bacterial meningitis. This invasive infection affects mostly infants, children, 
and adolescents who do not possess specific antibodies. 
Bacterial meningitis is an inflammation of the protective membranes 
covering the brain and spinal cord, known as the meninges. 
Based on the chemical composition of the polysaccharide capsule, 13 
different serogroups of N. Meningitidis have been defined so far, but only 
six serotypes (A, B, C, Y, W135 and recently X) are currently associated 
with significant pathogenic diseases. 
In particular, MenX is responsible of rare cases of meningococcal diseases 
in North America, Europe, Australia, Africa and Republic of China. The 
capsular polysaccharide (CPS) of Neisseria meningitidis X (Men X) is a 
homopolymer of (1→4)-linked 2-acetamido-2-deoxy-α-D-glucosamine 
phosphate residues (Figure 11). 
 
Figure 11. Repeating unito f MenX CPS 
 
 
In 2006 WHO started to consider MenX as a substantial threat for public 
health, suggesting to include this serotype as antigenic component in anti 
meningococcal conjugate vaccines. Since vaccines currently available do 
not contain this component, we became interested in the synthesis of Men 
X CPS fragments. 
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In our laboratory, short chain MenX oligomers were synthesized using the 
hydrogen phosphonate approach (Figure 12).1 
 
Figure 12. Synthetic monomer, dimer and trimer of MenX CPS 
 
 
However the synthesis of these fragments showed some significant 
drawbacks, such as the low yield in the final step of azide reduction and the 
long reaction time (ca. 10 days) required for the synthesis of the α-pure 
anomeric H-phosphonate. 
All these problems prompted us to investigate new routes for more efficient 
preparation of even longer Men X fragments. In particular, we decided to 
explore the use of microfluidic reactors for the synthesis of glycosyl 
phosphosaccharides. 
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1 Results and discussions 
 
In a previous work carried out in our laboraty, the preparation of two distinct 
intermediates (20 and 21) for the synthesis of MenX oligomers was 
optimized using standard batch conditions starting from commercially 
available D-glucosamine hydrochloride (Scheme 18).1 
 
Scheme 18. Synthesis of intermediates 20 and 21 
 
 
The subsequent steps of H-phosphonate preparation showed different 
problems. In particular, during the synthesis of the anomeric H-
phosphonate from the α-hemiacetal 20 with salicyl chlorophosphite in 
pyridine, the expected α-glycosyl H-phosphonate was obtained in very low 
yield (Scheme 19), and together with an unidentified compound also having 
α-configuration. 
 
Scheme 19. Synthesis of H-phosphonate 22 
 
 
In order to overcome this difficulty, the synthesis of the H-phosphonate at 
C-4 of 21 was tested. Any attempt to convert acceptor 21 into the H-
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phosphonate 23 (Scheme 20) in batch conditions gave disappointing 
results. 
 
Scheme 20. Synthesis of H-phosphonate 23 
 
 
Although two different batch conditions were tested (Table 6), the isolation 
of H-phosphonate 23 resulted unfeasible. 
 
Table 6. Batch conditions tested for the synthesis of 23 
entry solvent time (min) products 
1 Py 60 no product 
2 Py:CH3CN (1:1) 60 no product 
 
As an alternative option, the synthesis of the H-phosphonate under 
microfluidic condition was explored. The reaction was performed pumping 
into the microreactor two distinct solutions, containing the sugar residue 21 
in pyridine (0.1 M, Solution A) and salicyl chlorophosphite in CH3CN (0.2 M, 
Solution B). The device is completed by a reservoir connected to the outlet 
of the microreactor and containing a solution of Triethylammonium 
bicarbonate buffer (TEAB) 1.0 M to stabilize the H-phosphonate product 
(Figure 13). 
 
 145 
 
Figure 13. Diagramatic representation of continuous-flow H-phosphonate synthesis 
 
 
First, the synthesis of H-phosphonate 23 was tested under microfluidic 
conditions using a microreactor with an internal volume of 13 L. The 
results of this exploration are reported in Table 7. 
 
Table 7. Synthesis of 23 under microfluidic conditions 
entry residence time (sec) products (%yield) 
1 60 21 + 23 
2 120 21 + 23 
3 180 21 (trace) + 23 (54%) 
4 240 23 (58%) 
5 210 23 (59%) 
 
The first attempt was accomplished by setting the flow rate at 13 L/min 
corresponding to 60 seconds of residence time (Table 7, entry 1): under 
these conditions only a portion of 21 was converted to 23 (the unreacted 
alcohol 21 was recovered after flash chromatography). Therefore the 
residence time was increased to 120, 180 and 240 seconds. With 180 
seconds of residence time  unreacted alcohol 21 was still present (Table 7, 
entry 3), but it was fully consumed at 240 second of residence time (Table 
7, entry 4). 
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A additional attempt with residence time of 210 seconds (flow rate 3.7 
mL/min, Table 7, entry 5) demonstrated that an increase of residence time 
up to 240 seconds did not enhance the yield. 
Next, the synthesis of the anomeric H-phosphonate 22 under microfluidic 
conditions was investigated. For this purpose, the same instrumentation 
and procedure described in Figure 13 were used. In this case the reaction 
was carried out using a microreactor with an internal volume of 100 L. 
When the residence time was set to 3 minutes the H-phosphonate 22 was 
obtained in good yield (76%) exclusively in α configuration. 
To the best of our knowledge, these are the first examples of synthesis of 
H-phosphonate on saccharide substrates performed in a microreactor 
under continuous-flow conditions. 
 
Finally, the oxidative coupling in order to obtain the dimer 24 was explored. 
The reaction consists of a first coupling step between the H-phosphonate 
22 and the glycosyl acceptor 21, followed by the oxidation of the H-
phosphonate diester intermediate with iodine (Scheme 21). 
 
Scheme 21. Oxidative coupling between 22 and 21 
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The microreactor was used to perform the coupling under microfluidic 
condition (Solution A: 21 + 22 in Py; Solution B: PivCl in CH3CN), while the 
oxidation step was carried out in a standard round-bottomed flask under 
batch conditions, as depicted in Figure 14. 
Figure 14. Diagramatic representation of flow oxidative coupling 
 
 
The residence time into the microreactor was set to 3 minutes, then the 
mixture flowed out the reactor was collected and cooled to -40°C. At this 
point the oxidation was performed by a slow addition of I2 solution in a 
mixture Py-water. After 1 hour the reaction was quenched and the mixture 
purified by flash chromatography. The dimer 24 was obtained in low yield 
(5%), confirmed by NMR analysis, and no degradation products were 
observed. 
The synthesis of glycosyl phosphosaccharides associated to pathogenic 
microorganisms is a major goal for our laboratory. 
Further investigations will be therefore undertaken in order to obtain a 
reliable continuous-flow protocol suitable for the synthesis of various 
glycosyl phosphodiester under microfluidic conditions. 
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1 Experimental section 
 
1.1 General procedures 
The reactions performed under microfluidic conditions were carried out in a 
glass microreactor with an internal volume of 13 or 100 μL purchased by 
Micronit Microfluidics®. 
All commercially available reagents including dry solvents were used as 
received. Nonvolatile materials were dried under high vacuum. 
Reactions were monitored by thin-layer chromatography on pre-coated 
Merck silica gel 60 F254 plates and visualized by staining with a solution of 
cerium sulfate (1g) and ammonium heptamolybdate tetrahydrate (27 g) in 
water (469 mL) and concentrated sulfuric acid (31 mL). 
Flash chromatography was performed on Fluka silica gel 60. 
NMR spectra were recorded at 300 K on spectrometer operating at 400 
MHz. Proton chemical shifts are reported in ppm (δ) with the solvent 
reference relative to tetramethylsilane (TMS) employed as the internal 
standard (CDCl3 δ = 7.26 ppm). J values are given in Hz. Carbon chemical 
shifts are reported in ppm (δ) relative to TMS with the respective solvent 
resonance as the internal standard (CDCl3, δ = 77.0 ppm). 
High resolution mass spectra (HRMS) were performed with micro hybrid 
quadrupole time of flight (Q-Tof) Mass Spectrometer (Waters) with 
Electronspray Ionization (ESI) source and MassLinx NT software. 
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1.2 3-(N-Carbobenzyloxy)aminopropyl 1-O-(2-acetamido-4-
hydrogen-phosphonate-3,6-di-O-benzyl-2-deoxy--D-
glucopyranosyl phosphate) (23), bis-triethylamonium salt 
 
 
 
A solution of the glycosyl acceptor 21 (136 mg, 0.088 M) in pyridine (2 mL) 
was prepared (solution A). A solution of Salicyl chlorophosphite (71 mg, 
0.176 M) in CH3CN (2 mL) was prepared in a separate flask (solution B). 
Equal volumes (1 mL) of the two solutions were taken and injected into the 
microreactor (internal volume = 13 μL) via a double syringe pump, setting 
the flow rate at 1.85 L/min (total flow rate = 3.7 μL/min, corresponding to a 
residence time = 3.5 min). The mixture flowed from the microreactor was 
dropped in a TEAB 1.0M aqueous solution (1 mL) to quench the reaction. 
The reaction mixture was concentrated in vacuo and the crude was purified 
by flash chromatography (CH2Cl2/MeOH 9:1 + 1% TEA) to obtain the H-
phosphonate 23 as colourless oil (49 mg, 59%). 
 151 
 
1.3 2-Acetamido-4-O-acetyl-3,6-di-O-benzyl-2-deoxy--D-
glucopyranosyl hydrogen-phosphonate (22), 
triethylamonium salt 
 
 
 
A solution of the glycosyl acceptor 20 (89 mg, 0.1 M) in pyridine (2 mL) was 
prepared (solution A). A solution of Salicyl chlorophosphite (81 mg, 0.2 M) 
in CH3CN (2 mL) was prepared in a separate flask (solution B). Equal 
volumes (1 mL) of the two solutions were taken and injected into the 
microreactor (internal volume = 100 μL) via a double syringe pump, setting 
the flow rate at 16.5 L/min (total flow rate = 33.3 μL/min, corresponding to 
a residence time = 3 min). The mixture flowed from the microreactor was 
dropped in a TEAB 1.0M aqueous solution (1 mL) to quench the reaction. 
The reaction mixture was concentrated in vacuo and the crude was purified 
by flash chromatography (CH2Cl2/MeOH 9:1 + 1% TEA) to obtain the H-
phosphonate 22 as a white solid (46 mg, 59%). 
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1.4 3-(N-Carbobenzyloxy)aminopropyl 1-O-[2-Acetamido-3,6-di-
O-benzyl-2-deoxy--D-glucopyranosyl phosphate 4-(4-O-
Acetyl-2-acetamido-3,6-di-O-benzyl-2-deoxy--D-
glucopyranosyl phosphate)] (24), bis-triethylammonium 
salt 
 
 
A solution of H-phosphonate 22 (134 mg, 0.22 M) and glycosyl acceptor 21 
(155 mg, 0.2 M) in pyridine (1 mL) was prepared (solution A). A solution of 
PivCl (72 mg, 0.3 M) in CH3CN (2 mL) was prepared in a separate flask 
(solution B). Equal volumes (0.5 mL) of the two solutions were taken and 
injected into the microreactor (internal volume = 100 μL) via a double 
syringe pump, setting the flow rate at 16.5 μL/min (total flow rate = 33 
μL/min, corresponding to a residence time = 3 min). The reaction mixture 
flowed from the microreactor was collected in a separate flask. The solution 
was cooled to -40°C and a solution of I2 (38 mg, 0.15 mmol) in Py:H2O 19:1 
(1 mL) was slowly added. The temperature was raised up to 0°C, then a 
solution of Na2S2O3 0.5 M was added to quench the reaction. The mixture 
was extracted with CHCl3 (3 x 5 mL). The combined organic layers were 
washed with TEAB 1.0M, dried over Na2SO4, and concentrated in vacuo, 
and purified by flash chromatography (CH2Cl2/MeOH 9:1 + 1% TEA). 
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